# EDGAR Filing Document

**Accession Number:** 0001720725
**File Stem:** 9999999995-23-000038
**Filing Date:** 2023-1
**Character Count:** 1338
**Document Hash:** 94e252c568954c04578911ee71801f4b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-23-000038.hdr.sgml**: 20230106

**ACCESSION NUMBER**: 9999999995-23-000038

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230105

**DATE AS OF CHANGE**: 20230106

**EFFECTIVENESS DATE**: 20230105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oyster Point Pharma, Inc.
- **CENTRAL INDEX KEY:** 0001720725
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 811030955
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-249881
- **FILM NUMBER:** 23513619

**BUSINESS ADDRESS:**
- **STREET 1:** 202 CARNEGIE CENTER
- **STREET 2:** SUITE 106
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540
- **BUSINESS PHONE:** (609) 382-9032

**MAIL ADDRESS:**
- **STREET 1:** 202 CARNEGIE CENTER
- **STREET 2:** SUITE 106
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** January 5, 2023

**Accession Number:** 0001193125-23-000327

**Form Type:** POS AM

---

**CIK:** 0001720725

**Company Name:** Oyster Point Pharma, Inc.

**File Number:** 333-249881